These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 27148178)

  • 41. Characterization of antibiotic and disinfectant susceptibility in biofilm-forming Acinetobacter baumannii: A focus on environmental isolates.
    Pallós P; Gajdács M; Urbán E; Szabados Y; Szalai K; Hevesi L; Horváth A; Kuklis A; Morjaria D; Iffat W; Hetta HF; Piredda N; Donadu MG
    Eur J Microbiol Immunol (Bp); 2024 May; 14(2):126-133. PubMed ID: 38441568
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Investigation of the virulence factors of multidrug-resistant Acinetobacter baumannii isolates].
    Eraç B; Yılmaz FF; Hoşgör Limoncu M; Oztürk I; Aydemir S
    Mikrobiyol Bul; 2014 Jan; 48(1):70-81. PubMed ID: 24506717
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clonal evolution multi-drug resistant Acinetobacter baumannii by pulsed-field gel electrophoresis.
    Mohajeri P; Farahani A; Feizabadi MM; Norozi B
    Indian J Med Microbiol; 2015; 33(1):87-91. PubMed ID: 25560008
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Efficacy of Indolicidin, Cecropin A (1-7)-Melittin (CAMA) and Their Combination Against Biofilm-Forming Multidrug-Resistant Enteroaggregative Escherichia coli.
    Vergis J; Malik SVS; Pathak R; Kumar M; Sunitha R; Barbuddhe SB; Rawool DB
    Probiotics Antimicrob Proteins; 2020 Jun; 12(2):705-715. PubMed ID: 31485973
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Biofilm formation is not associated with worse outcome in Acinetobacter baumannii bacteraemic pneumonia.
    Wang YC; Huang TW; Yang YS; Kuo SC; Chen CT; Liu CP; Liu YM; Chen TL; Chang FY; Wu SH; How CK; Lee YT
    Sci Rep; 2018 May; 8(1):7289. PubMed ID: 29740176
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Biofilm formation in Haemophilus parasuis: relationship with antibiotic resistance, serotype and genetic typing.
    Zhang J; Xu C; Shen H; Li J; Guo L; Cao G; Feng S; Liao M
    Res Vet Sci; 2014 Oct; 97(2):171-5. PubMed ID: 25066803
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Biocide susceptibilities and biofilm-forming capacities of Acinetobacter baumannii clinical isolates from Malaysia.
    Nor A'shimi MH; Alattraqchi AG; Mohd Rani F; A Rahman NI; Ismail S; Abdullah FH; Othman N; Cleary DW; Clarke SC; Yeo CC
    J Infect Dev Ctries; 2019 Jul; 13(7):626-633. PubMed ID: 32065820
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Molecular Characterization of Multidrug Resistant Strains of
    Mohajeri P; Farahani A; Mehrabzadeh RS
    J Clin Diagn Res; 2017 Feb; 11(2):DC20-DC22. PubMed ID: 28384861
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antibioflm effects of extracellular matrix degradative agents on the biofilm of different strains of multi-drug resistant Corynebacterium striatum.
    Wen J; Wang Z; Du X; Liu R; Wang J
    Ann Clin Microbiol Antimicrob; 2022 Nov; 21(1):53. PubMed ID: 36434697
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Iron limitation enhances acyl homoserine lactone (AHL) production and biofilm formation in clinical isolates of Acinetobacter baumannii.
    Modarresi F; Azizi O; Shakibaie MR; Motamedifar M; Mosadegh E; Mansouri S
    Virulence; 2015; 6(2):152-61. PubMed ID: 25622119
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Phenotypical Comparison between Environmental and Clinical
    Boulesnam SL; Hamaidi-Chergui F; Benamara M; Azrou S
    Malays J Med Sci; 2023 Aug; 30(4):85-93. PubMed ID: 37655144
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Distribution of virulence-associated genes and antimicrobial susceptibility in clinical
    Liu C; Chang Y; Xu Y; Luo Y; Wu L; Mei Z; Li S; Wang R; Jia X
    Oncotarget; 2018 Apr; 9(31):21663-21673. PubMed ID: 29774093
    [No Abstract]   [Full Text] [Related]  

  • 53. Assessment of biofilm formation among clinical isolates of Acinetobacter baumannii in burn wounds in the west of Iran.
    Hatami Moghadam R; Alvandi A; Akbari N; Jafari P; Abiri R
    Cell Mol Biol (Noisy-le-grand); 2018 Dec; 64(15):30-34. PubMed ID: 30672433
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Biofilm formation in drug-resistant Acinetobacter baumannii and Acinetobacter nosocomialis isolates obtained from a university hospital in Pelotas, RS, Brazil.
    Amaral SC; Pruski BB; de Freitas SB; Dos Santos LM; Hartwig DD
    Lett Appl Microbiol; 2023 Aug; 76(8):. PubMed ID: 37563082
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Efflux Pump Inhibitor Phenylalanine-Arginine Β-Naphthylamide Effect on the Minimum Inhibitory Concentration of Imipenem in Acinetobacter baumannii Strains Isolated From Hospitalized Patients in Shahid Motahari Burn Hospital, Tehran, Iran.
    Gholami M; Hashemi A; Hakemi-Vala M; Goudarzi H; Hallajzadeh M
    Jundishapur J Microbiol; 2015 Oct; 8(10):e19048. PubMed ID: 26568800
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [In vitro synergistic activity of sulbactam in combination with imipenem, meropenem and cefoperazone against carbapenem-resistant Acinetobacter baumannii isolates].
    Turk Dagi H; Kus H; Arslan U; Tuncer I
    Mikrobiyol Bul; 2014 Apr; 48(2):311-5. PubMed ID: 24819268
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pan drug-resistant
    Sobouti B; Mirshekar M; Fallah S; Tabaei A; Fallah Mehrabadi J; Darbandi A
    Med J Islam Repub Iran; 2020; 34():24. PubMed ID: 32551313
    [No Abstract]   [Full Text] [Related]  

  • 58. Wide spread of Tn2006 in an AbaR4-type resistance island among carbapenem-resistant Acinetobacter baumannii clinical isolates in Taiwan.
    Lee HY; Chang RC; Su LH; Liu SY; Wu SR; Chuang CH; Chen CL; Chiu CH
    Int J Antimicrob Agents; 2012 Aug; 40(2):163-7. PubMed ID: 22743015
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Influence of whole-body washing of critically ill patients with chlorhexidine on Acinetobacter baumannii isolates.
    Mendoza-Olazarán S; Camacho-Ortiz A; Martínez-Reséndez MF; Llaca-Díaz JM; Pérez-Rodríguez E; Garza-González E
    Am J Infect Control; 2014 Aug; 42(8):874-8. PubMed ID: 24913762
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Persistence of Multidrug-Resistant Acinetobacter baumannii Isolates Harboring blaOXA-23 and bap for 5 Years.
    Sung JY; Koo SH; Kim S; Kwon GC
    J Microbiol Biotechnol; 2016 Aug; 26(8):1481-9. PubMed ID: 27221112
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.